NNC0537-1482 / Novo Nordisk - LARVOL DELTA

A Research Study Looking Into How a Single Dose of the Medicine NNC0537-1482 Moves Through the Body of Participants With Normal or Reduced Kidney Function (clinicaltrials.gov) - P1 | N=54 | Not yet recruiting | Sponsor: Novo Nordisk A/S

New P1 trial • Chronic Kidney Disease • Nephrology • Renal Disease

A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure (clinicaltrials.gov) - P1 | N=36 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting

Biomarker • Enrollment open • Cardiovascular • Congestive Heart Failure • Heart Failure

A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure (clinicaltrials.gov) - P1 | N=36 | Not yet recruiting | Sponsor: Novo Nordisk A/S

Biomarker • New P1 trial • Cardiovascular • Congestive Heart Failure • Heart Failure

A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin (clinicaltrials.gov) - P1 | N=31 | Completed | Sponsor: Novo Nordisk A/S | Recruiting ➔ Completed | N=56 ➔ 31

Enrollment change • Trial completion • Cardiovascular • Congestive Heart Failure • Heart Failure

A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin (clinicaltrials.gov) - P1 | N=56 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting

Enrollment open • Cardiovascular • Congestive Heart Failure • Heart Failure